0001104659-24-013851.txt : 20240212 0001104659-24-013851.hdr.sgml : 20240212 20240212095017 ACCESSION NUMBER: 0001104659-24-013851 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ayr Wellness Inc. CENTRAL INDEX KEY: 0001847462 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981500584 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-253466 FILM NUMBER: 24617775 BUSINESS ADDRESS: STREET 1: 199 BAY STREET STREET 2: SUITE 5300 CITY: TORONTO STATE: A6 ZIP: M5L 1B9 BUSINESS PHONE: 949-574-3860 MAIL ADDRESS: STREET 1: 666 BURRARD ST STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 2X8 6-K 1 tm245782d1_6k.htm FORM 6-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2024.

 

Commission File Number: 333-253466

 

Ayr Wellness Inc.
(Exact Name of Registrant as Specified in Charter)

2601 South Bayshore Drive, Suite 900, Miami, FL, 33133
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ¨ Form 40-F x

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    AYR WELLNESS INC.
    (Registrant)
       
Date: February 12, 2024 By: /s/ Brad Asher
    Name: Brad Asher
    Title:

Chief Financial Officer

 

 

 

 

EXHIBIT INDEX

 

99.1 News Release dated February 8, 2024

 

 

 

 EX-99.1 2 tm245782d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

 

 

AYR Wellness to Hold Fourth Quarter and Full Year 2023 Conference Call on March 13 at 8:30 a.m. ET

 

MIAMI, February 8, 2024 - AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, will hold a conference call on Wednesday, March 13, 2024, at 8:30 a.m. ET to discuss its results for the fourth quarter and full year ended December 31, 2023.

 

AYR President & CEO David Goubert and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call.

 

Date: Wednesday, March 13, 2024

Time: 8:30 a.m. ET

Toll-free dial-in number: (800) 319-4610

International dial-in number: (604) 638-5340

Conference ID: 10023064

Webcast: https://services.choruscall.ca/links/ayrwellness2023q4.html

 

A telephonic replay of the conference call will also be available for one month until end of day Saturday, April 13, 2024.

 

Toll-free replay number: (855) 669-9658

International replay number: (412) 317-0088

Replay ID: 0710

 

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at ir@ayrwellness.com.

 

About AYR Wellness Inc.

 

AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.

 

AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.

 

 

 

 

Company Contact:

 

Jon DeCourcey

Head of Investor Relations

T: (786) 885-0397

Email: ir@ayrwellness.com

 

Media Contact:

 

Robert Vanisko

VP, Public Engagement

T: (786) 885-0397

Email: comms@ayrwellness.com

 

Investor Relations Contact:

 

Sean Mansouri, CFA

Elevate IR

T: (786) 885-0397

Email: ir@ayrwellness.com

 

 

 GRAPHIC 3 tm245782d1_ex99-1img001.jpg GRAPHIC begin 644 tm245782d1_ex99-1img001.jpg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